Dongkoo Bio & Pharma Co., Ltd. is a biopharmaceutical company located in Seoul. They are a total healthcare leader, focusing on providing a healthy and happy future life. The company specializes in dermatology and urology drugs, but they are also expanding into internal medicine and otolaryngology. They have a strong manufacturing competitiveness for high-value-added specialty drugs and specialized formulations. In addition, they operate a bio business that includes the world's first stem cell kit and a new concept called Cellbloom. Dongkoo Bio & Pharma aims to become a total healthcare leader by encompassing prevention, diagnosis, treatment, and management. They prioritize R&D to strengthen their fundamental competitiveness and create new markets. The company also has plans to expand globally and become a company loved by customers and shareholders through sustainable management practices. Dongkoo Bio & Pharma is committed to going beyond the limits of a pharmaceutical company and making the leap to become a comprehensive company.
Headquarters
14F, B-Dong, 114, Beopwon-Ro, Songpa-Gu
Seoul; Seoul;
Contact Details: Purchase the Dongkoo Bio & Pharma Co.,Ltd. report to view the information.
Website: http://www.dongkoo.com
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service